| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.075 | 0.09 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |